FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to dermatology and can be used in treating sclerodermia. Versions of the invention provide using naltrexone in treating sclerodermia.
EFFECT: using the inventions enables reducing manifestations of sclerodermia, such as gratuitous synthesis and collagen deposits and fibrosis.
18 cl, 13 tbl, 2 ex
| Title |
Year |
Author |
Number |
| OPIOID RECEPTOR ANTAGONIST (NALTREXONE) APPLICABLE IN THERAPY OF HERPES ZOSTER |
2011 |
- Pisak Ibrakhim Mustafa Iskender
- Pisak Mekhmet
- Selamoglu Mekhmet Levent
- Bingol Semra
|
RU2561871C2 |
| ANTAGONISTS OF TOL-LIKE RECEPTOR 4 AND USE IN AUTOIMMUNE LIVER DISEASES |
2016 |
- U, Edvin, Essi
- Tszyu, Piter Dzhejes
- Syuj, Mej-Tszi
- Shi, In-Chzhu
|
RU2707560C2 |
| USE OF OPIOID RECEPTOR ANTAGONIST WITH K-ACTIVITY AND VORTIOXETINE FOR TREATMENT OF DEPRESSIVE DISORDER WITH MELANCHOLIC FEATURES |
2014 |
- Morillo Connie Sanchez
- Smagin Gennady N.
|
RU2679661C1 |
| COMPOSITIONS, DEVICES AND METHODS FOR THE TREATMENT OF ALCOHOL DEPENDENCE |
2017 |
- Crystal, Roger
- Agrawal, Arvind
- Maggio, Edward T.
|
RU2767062C2 |
| USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS |
2014 |
- Zhang Xiaoming
- Schnipper Edward F.
- Perlman Andrew J.
- Larrick James W.
|
RU2666219C2 |
| COMBINATIONS OF AGONIST/ANTAGONIST FOR OPIOID |
1998 |
- Kaiko Robert F.
- Koluchchi Robert D.
|
RU2241458C2 |
| COMPOSITIONS AND METHODS OF TREATING OPIOID OVERDOSE |
2017 |
- Crystal, Roger
- Maggio, Edward T.
|
RU2769397C2 |
| COMPOSITIONS AND METHOD FOR RELIEVING RESPIRATORY DISTRESS CAUSED BY OPIOID OVERDOSE |
2011 |
- Lemson Majkl Dzh.
- Goli Veerajndar
|
RU2541159C2 |
| NALMEFEN, NALTREXONE OR DERIVATIVES THEREOF FOR USE IN TREATING (NON)-ALCOHOLIC STEATOHEPATITIS OR NON-ALCOHOLIC FATTY LIVER DISEASE |
2017 |
- Wu, Edwin, Sc
- Chiu, Peter, J.S.
- Hsu, May, Mei-Chi
|
RU2717677C1 |
| METHOD FOR EXTRACTING NALMEPHENE HYDROCHLORIDE |
2012 |
- De Faveri Karla
- Stivanello Mariano
|
RU2631652C2 |
